Skip to content
RecallWatchMedical Device Safety
Class IOngoingZ-2604-2026

Insulet Corporation recalls Omnipod DASH Pod. Includes the below Model/REF Numbers: 1. POD-BLE-I1-525 (5-Pack)

Insulet CorporationActon, MA, United StatesReported Jul 8, 2026 · 1 month ago
Legal News Analyst ·

Reason for recall

External soft cannula damage during manufacturing that results in insulin leaking around the Pod instead of being delivered to the user regardless of basal or bolus delivery. The primary failure mode is pump under-delivery due to loss of insulin to an external leak. If insulin is not delivered properly, users may experience high blood glucose levels due to under-delivery of insulin. In the most severe cases, prolonged and persistent high blood glucose levels can lead to diabetic ketoacidosis (DKA), hyperglycemic hyperosmolar syndrome (HHS), or even death.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Omnipod DASH Pod. Includes the below Model/REF Numbers: 1. POD-BLE-I1-525 (5-Pack), POD-BLE-I1-520 (Single Pod). 2. POD-BLE-I1-529 (10-Pack), POD-BLE-I1-520 (Single Pod). 3. BLE-I1-529 (10-Pack), BLE-I1-520 (Single Pod). 4. BLE-C1-529 (10-Pack), BLE-C1-520 (Single Pod)
    UDI-DI 20385082000051.REF Number
    64 affected lots
    PD1U11052421PD1U11012421PD1U11022421PD1U02152521PD1U02192521PD1U04242522PD1U10282522PD1U10292521
    +56 morePD1U10302521PD1U10312521PD1U11032521PD1U11042521PD1U01082621POD-BLE-I1-529POD-BLE-I1-5202038508200002010385082000023PD1U11192421PD1U09102421PD1U09092421PD1U09062421PD1U10242421PD1U10252421PD1U10282421PD1U10292421PD1U10312421PD1U11042421BLE-I1-529BLE-I1-5202038508200002010385082000023PD1U11152421PD1U11182421PD1U11202421PD1U09042421PD1U11132421PD1U11122421PD1U11142421PD1U11152411PD1U11162421PD1U04292521PD1U09032421PD1U11112421PD1U04262521BLE-C1-529BLE-C1-5202038508200011210385082000115PD1U03042521PD1U09052421PD1U11072421PD1U11082421PD1U03062521PD1U03032521PD1U03072521PD1U02282525PD1U02282526PD1U04252521PD1U11062521PD1U11072521PD1U11102521PD1U11112511PD1U11112522PD1U11122521

What the firm is doing

Insulet initially issued a press release on 05/26/2026 along with an "Urgent: Medical Device Correction" on the same day. Consignees were notified of the issue and hazard and instructed to not used Pods from affected lots and to check the lot number on the Pod tray lid, box or Pod itself to determine if affected Pods are on hand. If impacted Pods are on hand, consignees were instructed to discontinue use of any impacted Pod immediately, immediately change the Pod if currently using an affected lot, and acknowledge the email confirming receipt. Confirming receipt of the email is needed even if no affected Pods are on hand. Customers will receive a return kit with clear instructions on how to send back any unused affected Pods.

DistributionShow details

Worldwide distribution - US Nationwide and the countries of Austria, Australia, Belgium, Canada, Switzerland, Germany, Denmark, Finland, France, UK, Greece, Israel, Italy, Kuwait, Leichtenstein, Netherlands, Norway, Saudi Arabia, Sweden and Turkey.

Class IWhat this means

A reasonable probability that use of the product will cause serious adverse health consequences or death.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class I recalls

Class IOngoingZ-2879-2026

Boston Scientific Neuromodulation Corporation recalls INFINION CX LEAD KIT

Spinal cord stimulation system lead body may be exposed to stress at the anchor site. This may result in high impedance measurements or lead fractures, which may lead to inadequate stimulation, additional intervention, i…

  • Totally Implanted For Pain Relief Spinal-Cord Stimulator
  • Device Design
Boston Scientific Neur…CAAug 12, 2026